- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Melanoma, Malignant in Canada
Total 425 results
-
National Cancer Institute (NCI)CompletedIntraocular Melanoma | Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Extraocular Extension Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Superficial... and other conditionsCanada
-
Grupo Español Multidisciplinar de MelanomaGlaxoSmithKlineCompletedMalignant Melanoma Stage IV | Malignant Melanoma Stage IIIcSpain
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Wilson MillerActive, not recruitingMetastatic Malignant MelanomaCanada
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompletedAdvanced Ovarian Cancer | Malignant MelanomaCanada
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
Jewish General HospitalActive, not recruitingUntreated Stage III Melanoma or Stage IV MelanomaCanada
-
AHS Cancer Control AlbertaTransplant Genomics, Inc.Unknown
-
University Health Network, TorontoRecruitingCutaneous Melanoma | Mucosal Melanoma | Melanoma Stage IVCanada
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Uveal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension MelanomaCanada, United States
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLCTerminated
-
University Health Network, TorontoCompletedMetastatic, Stage III or Stage IV, MelanomaCanada
-
Sunnybrook Health Sciences CentreTerry Fox Research InstituteRecruiting
-
Immunovia, Inc.CompletedPancreatic Ductal Adenocarcinoma | Familial Pancreatic Cancer | FAMMM - Familial Atypical Mole Malignant Melanoma SyndromeUnited States, Sweden, Canada, Spain, United Kingdom
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Carman GiacomantonioNova Scotia Health AuthorityTerminatedMelanoma (Skin) | Melanoma in SituCanada
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Stage IIIB Cutaneous Melanoma AJCC v7United States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...United States, Canada, Ireland
-
University Health Network, TorontoNot yet recruiting
-
AHS Cancer Control AlbertaCompleted
-
NCIC Clinical Trials GroupZymoGeneticsCompletedMelanoma (Skin)Canada
-
University Health Network, TorontoCompleted
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
Lawson Health Research InstituteActive, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedMelanoma | Hypertension | Non-melanoma Skin CancerCanada
-
Apexigen America, Inc.TerminatedMelanoma | Cancer | Metastatic Melanoma | Melanoma (Skin) | Unresectable Melanoma | Cancer of SkinSpain, Poland
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
National Cancer Institute (NCI)CompletedIris Melanoma | Stage IV Uveal Melanoma | Medium/Large Size Posterior Uveal Melanoma | Recurrent Uveal Melanoma | Ocular Melanoma With Extraocular Extension | Small Size Posterior Uveal MelanomaUnited States, Canada
-
Grupo Español Multidisciplinar de MelanomaCompleted
-
Grupo Español Multidisciplinar de MelanomaRecruitingAdvanced Cancer | Melanoma Stage Iv | Melanoma Stage IiiSpain
-
NCIC Clinical Trials GroupCompleted
-
Novartis PharmaceuticalsCompletedMalignant MelanomaCanada, Italy, Czechia, Australia, France, Greece, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Slovakia, Slovenia, Japan, Turkey, Argentina, Finland, Norway, Brazil, Latvia, Lithuania, Poland, Portugal
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands